Andrew Oddy looks back on his career as Keeper of Conservation at the British Museum and the exposure test that bears his name ...
The scientific community called the group’s July 2025 report ‘fundamentally incorrect.’ The EPA can use it to slash ...
The London biotech will develop small-molecule therapies to target a pathway some cancer cells use to lengthen their life ...
The administration wants to lean on allies, stockpiles, and targeted investments to compete with China, while experts warn of market distortion and call for innovative alternatives ...
The US Food and Drug Administration has rejected a small molecule for a rare blood disorder called erythropoietic protoporphyria. Bitopertin, originally developed by Roche and licensed by Disc ...
Food chains in the coral reefs of the Caribbean are up to 70% shorter today than in the past, and fish living there have a ...
By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...
This reassessment of BHA is the first in a larger post-market review program for food chemicals started by the Joe Biden ...
Matthew Fuchter, who develops novel molecular systems at the University of Oxford, calls this “an exciting study [that] ...
Overbuilding and tepid demand have led to tough market conditions for petrochemical producers around the world. Learn about ...
The US Environmental Protection Agency (EPA) announced Feb. 6 that it approved the registration of three dicamba-based ...
Highly exposed people have begun taking cholestyramine, but experts caution that evidence is lacking on whether the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results